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Abstract  
Objectives: The study is intended to evaluate the role of Ki-67 immunoexpression in the diagnosis of molar 
pregnancy & differential diagnosis of its subgroups from miscarriage.  
Methods: Sixty eight formalin-fixed, paraffin- embedded specimens of products of conception , including 1st 
trimester miscarriage (n=15), partial hydatidiform mole PHM (n=24), complete hydatidiform CHM (n=24) and full 
term placenta (n=5), all were examined at Histopathology Department of Maternity Teaching Hospital in Erbil, Iraq 
during the period Sep.2012-Sep.2013. Ki-67 immunohistochemical staining was performed by using the monoclonal 
antibody MIB-1 and the standard streptavidin-biotin immunoperoxidase method. The labeling index (number of 
positive nuclei/total number of nuclei) for villous, cytotrophoblasts , syncytiotrophoblasts and stromal cells were 
evaluated separately. Statistical analysis was carried out by Fisher’s exact test & statistical significance was 
determined at p < 0.05.  
Results: The study shows that all villous trophoblastic lesions showed high Ki-67 in all villous components 
especially cytotrophoblasts, being the highest in CHM mole(>50%) followed by PHM (>20%). Also found a 
statistically significant differences in immunoexpressins of Ki-67 that was useful in separating miscarriage from 
CHM, p<0.01 (highly significant), and partial hydatidiform mole p<0.05, (significant).  
Conclusion: Ki-67 labeling index of villous cells ,especially cytotrophoblasts, is valuable in diagnosis and 
differentiation of hydatidiform mole from 1st trimester miscarriage as well as between different subgroups of 
hydatidiformmoles (CHM & PHM). 
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Introduction  
     Trophoblastic diseases constitute a spectrum of tumors and tumor- like conditions 
characterized by proliferation of pregnancy associated trophoblastic tissue of progressive 
malignant potential. The lesions include Hydatidiform mole HM ( Complete Hydatidiform mole 
CHM and Partial Hydatidiform mole PHM ), invasive mole, and malignant Choriocarcinoma (1). 
Accurate diagnosis and classification of HM is important as the risk of persistent gestational 
trophoblastic disease, including the CC, is significantly high. The risk of CC in CHM is 10% – 
30% and in PHM is 0.5% – 5% (2). Despite well-described histopathologic criteria, the distinction 
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of spontaneous miscarriage from HM and CHM from PHM remains a problem because of 
interobserver and intraobserver variability (3). Thus, development of new methods that allow 
differentiating these diseases in doubtful cases is important. A complementary method to the 
pathologic interpretation is immunohisto-chemistery (IHC). Among the immunohistochemical 
markers, proliferation markers such as Ki-67 have been established as a valuable reflection of the 
tissue proliferative compartment and thus could be of value in studying the biologic behavior of 
gestational tophoblastic diseases (4). Ki-67 is a labile non histone nuclear protein that is tightly 
linked to the cell cycle, it is expressed in proliferating cells during mid G1 phase, increasing 
level through S and G2 phases and peaking in the M phase of the cell cycle. It is rapidly 
catabolized at the end of M phase and it’s undetectable in resting cells and during DNA repair 
process, compared with other proliferative markers, Ki-67 staining is easy to perform, 
economical and more reproducible (5.6). The Ki-67 gene is present on the long arm of human 
chromosome 10 (10 q25) and its half life has been estimated approximately 60-90 minutes (7). 
The aim of this study was to evaluate the value of Ki-67 immunoexpression in diagnosis of 
molar pregnancy & in the differential diagnosis of subgroups of HM from miscarriage. 
Materials and Methods  
During the period between Jan 2011-Jun 2013, the pathology archives of the Maternity 
Teaching Hospital & some private histopathological laboratories were searched for the 
pathological diagnosis of molar pregnancy & 1st trimester non molar miscarriage. A total of (68) 
formalin fixed & paraffin-embedded samples of products of conception were randomly selected 
and categorized into the following groups: 1st trimester miscarriage (n=15), PHM(n=24), 
CHM(n=24), in addition 5 samples of full term placenta were included as a negative control. All 
the blocks were examined and the one which represented the diagnosis best (no necrosis, no 
hemorrhage) was selected for the study and new section was made and stained with hematoxylin 
and eosin (H&E) for histological reevaluation, In order to differentiate PHM from CHM the 
histologic features of the specimen were assessed according to diagnostic agreed with the 
histopathological criteria (8), another thin 4 mm section was made and submitted for IHC. The 
study was approved by the Ethical Committee of the College of Medicine, Hawler Medical 
University, Erbil, Iraq.  
Immunostaining: Immunohistochemistry was performed using the avidin-biotin-peroxidase 
complex in which primarily monoclonal antibodies raised against Ki-67 (Dako Cytomation, 
Denmark, clone MIB1) were used & according to Dako Cytomation EnVisionR+Dual link 
system-HRP(DAB+) staining protocol for immunostaining as the manufacturer’s instructions 
described in the leaflet supplied with the antibody. Briefly, for antigen retrieval, deparaffinized 
sections were pretreated by being heating in a microwave oven in 10 mM citrate buffer, pH 6.0, 
for 20 minutes. After cooling, sections were immersed in phosphate buffered saline (PBS) 
containing 3% hydrogen peroxide for 10 min to block endogenous peroxidase activity. Sections 
were then incubated in a humid chamber overnight at 4°C with the following primary antibodies: 
Ki-67 (clone MIB-1; dilution 1:100; DakoCytomation R, Denmark). After rinsing with PBS, 
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slides were incubated with a secondary antibody followed by streptavidin-biotin-peroxidase 
complex, both for 30 min at room temperature with a PBS wash between each step (LSAB+ 
system; DakoCytomationR, USA Denmark). The slides were developed with diaminobenzidine-
H2O2 (DAB+ system; DakoCytomationR, USA), counterstained with Harry’s hematoxylin and 
mounted. Negative controls, in which N-universal negative control replaced the primary 
antibody, were run with each batch of stain and breast cancer sections known to stain strongly 
positive for Ki-67 was included with each run as positive controls.  
Assessment of nuclear accumulation of Ki-67: For Ki-67 immunoexpression, the evaluation 
was conducted by using a semi quantitative scoring method by determining the proportion of +ve 
cells over total numbers of cells. All significantly stained cells were counted and the labeling 
index (LI) were determined by counting 1000 cells then divided by 10 to acquire the percentage ; 
at least 10 HPF were measured for each case for the purpose of scoring. The LI in miscarriage 
and molar pregnancy were evaluated separately for cytotrophoblasts (cyto.), syncytiotrophoblasts 
(syn.), and stromal cells by counting 1000 cells for each population .Also the distribution of Ki-
67 immunoreactivity in trophoblastic diseases were quantitatively assessed as -ve (equal or less 
than 10% are positive cells) & +ve (more than 10% are positive cells) and the positive cases 
were graded as: + (10-20%) ; ++ (20-50 %); and +++ ( more than 50%) are positive cells.  
Statistical analysis:- Data were analyzed using the statistical package for social sciences (SPSS, 
version 19). The results obtained from each case groups were compared in pairs for the following 
parameters included in the study(Ki-67 LI and distribution of Ki-67 immunostaining) by means 
of Fischer’s exact test. A p value of ≤ 0.05 was considered statistically significant, and p value 
<0.01 was considered statistically highly significant. 
Results  
The mean age (± SD) for miscarriage was 29.6 ±3.7yrs, range: (20 - 42 ) ; for PHM 
29.03±2.1 yrs., range: (20 - 40 ) & for CHM 31.04±3.3 yrs., range: ( 17- 50). Specific staining of 
Ki-67 protein with monoclonal antibody MIB-1 was confined to the nuclei of cyto., syn. & 
stromal cells of placental villi. Figure (1).  
 
Table (1):-Ki-67 LI in miscarriage & molar pregnancy in all villous components  
 
Type of lesion Ki-67 LI in Cyto. Ki-67 LI in Syn.  Ki-67 LI in stromal 
cells 
Miscarriage 7±4.971 3.3733±3.615 2.867±3.159 
PHM 22.5±16.611 17.833±15.228 11.292±10.732 
CHM 68.542±11.275 53.958±9.778 39.375±11.545 
     
 
All full term placenta specimens showed negative Ki-67 immunostaining in all components 
of villi, while 1st trimester miscarriage showed positive Ki-67 immunostaining of villi with a LI 
=7±4.971, 3.3733±3.615, 2.867±3.159 in cyto., syn. & stromal cells respectively . In comparison 
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with Ki-67 LI of 1st trimester miscarriage (control group), molar pregnancy (PHM &CHM) 
showed a higher Ki-67 LI of all villous components especially of cyto. ; being the highest in 
CHM (68.542±11.275 ) then PHM (22.5±16.611). The lowest Ki-67 LI observed in stromal cells 
of villi in both molar pregnancy & miscarriage, while Ki-67 LI of syn. was in between them. As 
shown in Table (1). 
Table(2):- Distribution of Ki-67 immunoreactivity in miscarriage and HM 
Type of 
lesion 
 
Cytotrophoblasts. No. (%)  
 
 
Syncytiotrophoblasts. No. (%)  
 
 
Stromal cells No. 
(%)  
 
+ ++ +++ -ve + ++ +++ -ve + ++ +++ -ve 
Miscarria
ge 
1 
(6.7) 
0 0 14 
(93.3) 
1 
(6.7) 
0 0 14 
(93.3) 
1 
(6.7) 
0 0 14 
(93.3) 
PHM 0 12 
(50) 
1 
4.2 
11 
(45.8) 
6 
(25) 
5 
(21) 
0 13 
(54) 
4 
(16.6) 
4 
(16.6) 
0 16 
(66.8) 
CHM 0 0 24 
(100) 
0 0 20 
(83.3) 
4 
(16.6) 
0 0 20 
(83.3) 
4 
(16.6) 
0 
+ 10-20%; ++ 20-50; +++ > 50%; -ve < 10% 
     Regarding the distribution of Ki-67 LI in miscarriage and villous lesions; fourteen out of 
fifteen cases (93.3%) of first-trimester miscarriage had a LI ≤10% in all cell populations (cyto. 
,syn. & stromal cells) of villi . All 24 cases (100%) of CHM showed positive Ki-67 
immunoexpression in all villous components with a LI above 50% in all cases. while 12/24 cases 
(50%) of PHM had Ki-67 LI above 20% and below 50% in cyto. Only one case of PHM had a LI 
above 50% in cyto. Table (2).  
     In order to study the role of Ki-67 immunoexpression in differentiating these trophoblastic 
lesions, the data of these three groups (miscarriage, PHM & CHM ) were analyzed, matched in 
pairs & evaluated statistically according to their Ki-67 expressions(Table 3). A significant 
difference was found between Ki-67 immunoexpression in cyto. of miscarriage & PHM (p< 
0.05) and there was a highly significant difference between Ki-67 immunoexpression of all 
villous components of miscarriage & CHM and those of PHM & CHM (p< 0.01). 
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Table (3): Statistic comparison of Ki-67 immunoexpression between miscarriage and hydatidiform 
mole in all villous components 
Type of 
lesion 
Cyto. P value Syn. P value Stromal 
cells 
P value 
+ve -ve +ve -ve +ve -ve 
Miscarriage 
 
 
 
PHM 
2 
 
 
 
13 
13 
 
 
 
11 
 
 
0.0173** 
1 
 
 
 
11 
14 
 
 
 
13 
 
 
0.0131** 
1 
 
 
 
8 
14 
 
 
 
16 
 
 
0.1152* 
Miscarriage 
 
 
 
CHM 
2 
 
 
 
24 
13 
 
 
 
0 
 
 
<0.0001*** 
1 
 
 
 
24 
14 
 
 
 
0 
 
 
<0.0001*** 
1 
 
 
 
24 
14 
 
 
 
0 
 
 
<0.0001*** 
PHM 
 
 
 
CHM 
13 
 
 
 
24 
11 
 
 
 
0 
 
 
0.0003*** 
11 
 
 
 
24 
13 
 
 
 
0 
 
 
<0.0001*** 
8 
 
 
 
24 
16 
 
 
 
0 
 
 
<0.0001*** 
 
*Non significant (p>0.05), ** significant (p≤0.05), *** Highly significant(p≤0.01) 
 
Discussion  
Gestational trophoblastic diseases are defined as a spectrum of abnormal gestations and 
neoplasms arising from villous or extravillous trophoblasts that are associated with pregnancy. 
They takes several forms, each with its own risk of mortality and responsiveness to 
chemotherapy. Differential diagnosis of these diseases by routine histopathologic examination 
can be challenging. Studies have recently shown that IHC for various markers is useful for 
confirming the diagnosis & it is a complementary method to pathologic interpretation (4).One of 
the advantages of this method is the ability to apply them retrospectively to sections of routinely 
formalin-fixed and paraffin-embedded tissue and there is no need for expensive or sophisticated 
equipments. In this study we investigated the immunoexpression of a proliferation marker (Ki-
67) protein in various trophoblastic diseases. 
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Figure (1): Complet hydatidiform mole with positive nuclear Ki-67 immunoexpression. 
      All full term placenta specimens showed negative Ki-67 immunostaining in all components 
of villi; while 1st trimester miscarriage showed positive nuclear Ki-67 immunostaining of all 
villous components with a LI =7±4.971, 3.3733±3.615, 2.867±3.159 in cyto. , syn. & stromal 
cells respectively. This indicated that full term placenta did not have any proliferative activity 
while 1st trimester villi had some proliferative activity especially the cyto. ; But in the majority 
of miscarriage cases (93.3%) the value did not exceed 10%, In hydatidiform mole, Ki-67 LI was 
higher than that of miscarriage (i.e ≥ 10%), many other studies showed the same results(9,10,11). i.e 
Ki-67 immunoexpression in miscarriage was less than in molar pregnancy.  
      It seemed that among these three groups of villous cells (cyto., syn ., and stromal cells), the 
highest Ki-67 LI was in cyto. of all villous trophoblastic lesions. This comes in agreement with 
two other studies done (4,12). The highest Ki-67 LI was in cyto. of CHM (68.542±11.275 ) 
followed by PHM (22.5±16.611).The lowest Ki-67 LI observed in stromal cells of villi in all 
villous lesions while Ki-67 LI of syn. was in between. This indicates that Ki-67 LI of cyto. is the 
best index in separating these three entities, three other studies showed the same results .(4,13,14) 
   The distribution of Ki-67 immunoexpression in miscarriage and villous trophoblastic lesions 
(table 2) comfirmed that 10% is a good cutoff value in reading & separating positive Ki-67 
immunoexpression (≥10%) from negative ones (< 10%). Majority of miscarriage cases (93.3%) 
showed –ve Ki-67 immunoreactivity in all villous cella while all CHM cases (100%) had +ve Ki-
67 immunoexpression with a value above 50% in all villous cells. For PHM, more than half of 
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cases (54.2%) had +ve Ki-67 immunoexpression in cyto. cells. Other studies as Hasanzadeh (13) 
prefered to use 12.5% & 6% as a cut off value for reading Ki-67 immunoexpression in cyto. & 
syn. cells respectively.  
   There was a statistically significant differences in Ki-67 immunoexpression in both cyto. and 
syn. between miscarriage and PM (p<0.05); there also were extremely significant differences in 
Ki-67 immunoexpression found between miscarriage and CHM and between PHM and CHM, in 
all villous cells(p<0.01).This indicated that expression of Ki-67 is useful in separating 
miscarriage from CHM & PHM, and in differentiation between CHM & PHM, some other 
studies showed similar findings (9-11) while others as Jeffers (15) did not detect any significant 
difference in Ki-67 expression between patients with CHM complicated by gestational 
trophoblastic neoplasia and molar pregnancy that resolved spontaneously.  
 
Conclusion  
Ki-67 labeling index of villous cells ,especially cytotrophoblasts, is valuable in diagnosis 
and differentiation of hydatidiform mole from 1st trimester miscarriage as well as between 
different subgroups of hydatidiformmoles (CHM & PHM). 
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 الخلاصة
 في تشخيص الحمل العنقودي وتمييزها عن الانواع الأخرى لأنواع اجهاض الحمل.  76-iKلدراسة دور التعبير المناعي ل   -الهدف:
نموذج)،  51ثمان وستون نموذج لنواتج الحمل المثبتة بالفورمالين والمطمورة بالفورمالين ، والتي شملت أجهاض الحمل في الأشهر الأولى ( -العمليات:
نموذج). جميع النماذج تم جمعها من مختبرات  5نموذج)  ومشيمة الحمل الكامل  ( 42نموذج)، حمل عنقودي كامل (  42عنقودي جزئي (  حمل
ي ل . تم استخدام التصبيغ المناعي الهيستوكيمياو 3102ايلول  -2102فحص الأنسجة  في مستشفى الولادة في اربيل / العراق خلال الفترة من ايلول 
) لكل عدد الأنوية الكليعدد الأنوية المصبوغة/( 76-iKوباستخدام الطريقة المعتادة . المؤشر التعريفي ل 1-BIMوباستعمال المضاد الأحادي  76-iK
ئية تم حصامن الزغابات المشيمة  والجذعة الغذائية الخلوية والجذعة الغذائية المخلاوية والخلايا السدوية تم حسابها بصورة منفصلة. الحسابات الأ
 تم اعتباره ذو قيمة أحصائية. 50.0أقل من  pواذا كانت قيمة ال  rehsiFاجراءها بأستخدام مؤشر 
 في كل امراض الزغابات المشيمية كان عالي وبصورة خاصة في الزغابات المشيمية للحمل العنقودي 76-iKأظهرت الدراسة أن مؤشر ال   -النتائج:
والتي كانت   76-iK). كذلك تم ايجاد علاقة ذو قيمة احصائية  للتعبير المناعي لل %02>العنقودي الجزئي ( ) ثم في الحمل  %05>الكامل  (
 ).50.0<p) والحمل العنقودي الجزئي ( 10.0<pمفيدة في التمييز بين الأجهاض والحمل العنقودي الكامل ( 
 ذو قيمة في تشخيص وتمييز الحمل العنقودي من الأجهاض في الأشهر الأولى في الزغابات المشيمية كان  76-iKالمؤشر التعريفي ل  -الأستنتاج:
 للحمل وكذلك في تمييز الحمل العنقودي الكامل من الحمل العنقودي الجزئي .
 . 76-iKحمل عنقودي جزئي، حمل عنقودي كامل ، اجهاض، التعبير المناعي  الدالة:الكلمات 
